Oral Antiviral Drug, Molnupiravir, Phase 1 Clinical Trial - InvExDis Video

A memento to remember the things you learned. In this video, we reviewed the phase 1 clinical trial of molnupiravir, a broad-spectrum antiviral oral medication developed by Ridgeline Therapeutics. These data show the safety profile and pharmacokinetics of molnupiravir for the first time in humans.